Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N-(4-Aminobenzoyl)-L-glutamic acid is a dipeptide that is formed through the formal condensation of the carboxylic acid group of 4-aminobenzoic acid with the amino group of L-glutamic acid. It is a light tan, waxy solid and is known to be a major metabolite of 5-Methyltetrahydrofolic Acid.

4271-30-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 4271-30-1 Structure
  • Basic information

    1. Product Name: N-(4-Aminobenzoyl)-L-glutamic acid
    2. Synonyms: H-4-ABZ-GLU-OH;4-AMINOBENZOYLGLUTAMIC ACID;4-AMINOBENZOIC GLUTAMIC ACID;N-(P-AMINOBENZOYL)-L-GLUTAMIC ACID;P-AMINOBENZOYL-L-GLUTAMIC ACID;P-AMINO BENZAMIDE GLUTAMIC ACID;N-(4-AMINOBENZOYL)-L-GLUTAMIC ACID;4-aminobenzoyl-L-glutamic acid
    3. CAS NO:4271-30-1
    4. Molecular Formula: C12H14N2O5
    5. Molecular Weight: 266.25
    6. EINECS: 224-261-7
    7. Product Categories: Amino Acids;A - HPeptide Synthesis;Amino Acid Derivatives;Amino Acids;Glutamic Acid;Modified Amino Acids;Amino Acids & Derivatives;Metabolites & Impurities;amino;Intermediate
    8. Mol File: 4271-30-1.mol
  • Chemical Properties

    1. Melting Point: ~175 °C (dec.)
    2. Boiling Point: 409.45°C (rough estimate)
    3. Flash Point: 320.9 °C
    4. Appearance: /
    5. Density: 1.2846 (rough estimate)
    6. Vapor Pressure: 1.37E-15mmHg at 25°C
    7. Refractive Index: 1.6660 (estimate)
    8. Storage Temp.: −20°C
    9. Solubility: Aqueous Base (Sparingly), Aqueous Acid (Sparingly), DMSO (Sparingly), Methanol (
    10. PKA: 3.50±0.10(Predicted)
    11. Stability: Hygroscopic
    12. Merck: 14,426
    13. BRN: 2816320
    14. CAS DataBase Reference: N-(4-Aminobenzoyl)-L-glutamic acid(CAS DataBase Reference)
    15. NIST Chemistry Reference: N-(4-Aminobenzoyl)-L-glutamic acid(4271-30-1)
    16. EPA Substance Registry System: N-(4-Aminobenzoyl)-L-glutamic acid(4271-30-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: 36/37/38
    3. Safety Statements: 26-36/37/39
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 4271-30-1(Hazardous Substances Data)

4271-30-1 Usage

Uses

1. Used in Pharmaceutical Industry:
N-(4-Aminobenzoyl)-L-glutamic acid is used as a marker in folate metabolism studies for its role in the metabolism of 5-Methyltetrahydrofolic Acid, which is essential for various biological processes, including DNA synthesis and repair.
2. Used in Research and Development:
As a major metabolite of 5-Methyltetrahydrofolic Acid, N-(4-Aminobenzoyl)-L-glutamic acid is utilized in research and development to study the effects of folate metabolism on various health conditions and to develop potential therapeutic strategies targeting this metabolic pathway.
3. Used in Diagnostic Applications:
N-(4-Aminobenzoyl)-L-glutamic acid can be employed as a diagnostic marker to monitor the levels of 5-Methyltetrahydrofolic Acid in patients, which may help in the early detection and management of conditions related to folate metabolism dysregulation.
4. Used in Nutritional Supplements:
Due to its involvement in essential biological processes, N-(4-Aminobenzoyl)-L-glutamic acid may be used as an ingredient in nutritional supplements to support overall health and well-being, particularly in individuals with deficiencies or imbalances in folate metabolism.
5. Used in Drug Development:
The understanding of the role of N-(4-Aminobenzoyl)-L-glutamic acid in folate metabolism can be leveraged in the development of new drugs targeting specific health conditions related to this metabolic pathway, potentially leading to novel therapeutic options for patients.

Purification Methods

Crystallise the acid from H2O. Also purify it by dissolving 2.7g in H2O (130mL), adding aqueous NaOH to pH 5.5 and adding portionwise a solution of 0.5M CuSO4 to complete precipitation of the Cu salt. This salt is filtered off, suspended in H2O and H2S is bubbled through to precipitate CuS, filter, evaporate and recrystallise the residue from H2O. It has max (H2O) at 273nm. [Backer & Houtman Recl Trav Chim Pays-Bas 70 738, 743 1951, Beilstein 14 IV 1153.]

Check Digit Verification of cas no

The CAS Registry Mumber 4271-30-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,2,7 and 1 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 4271-30:
(6*4)+(5*2)+(4*7)+(3*1)+(2*3)+(1*0)=71
71 % 10 = 1
So 4271-30-1 is a valid CAS Registry Number.
InChI:InChI=1/C12H14N2O5/c13-8-3-1-7(2-4-8)11(17)14-9(12(18)19)5-6-10(15)16/h1-4,9H,5-6,13H2,(H,14,17)(H,15,16)(H,18,19)/t9-/m1/s1

4271-30-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A0442)  N-(4-Aminobenzoyl)-L-glutamic Acid  >97.0%(T)

  • 4271-30-1

  • 1g

  • 780.00CNY

  • Detail
  • TCI America

  • (A0442)  N-(4-Aminobenzoyl)-L-glutamic Acid  >97.0%(T)

  • 4271-30-1

  • 5g

  • 2,590.00CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1334)  N-(4-aminobenzoyl)-L-Glutamic acid (Folic Acid Imp A)  pharmaceutical secondary standard; traceable to PhEur

  • 4271-30-1

  • PHR1334-500MG

  • 952.15CNY

  • Detail
  • Sigma-Aldrich

  • (Y0001242)  Folic acid impurity A  European Pharmacopoeia (EP) Reference Standard

  • 4271-30-1

  • Y0001242

  • 1,880.19CNY

  • Detail
  • USP

  • (1019870)  4-Aminobenzoylglutamic acid  United States Pharmacopeia (USP) Reference Standard

  • 4271-30-1

  • 1019870-50MG

  • 4,326.66CNY

  • Detail
  • Sigma

  • (A0879)  N-(4-Aminobenzoyl)-L-glutamic acid  ≥98% (TLC)

  • 4271-30-1

  • A0879-5G

  • 3,445.65CNY

  • Detail

4271-30-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-aminobenzoyl)-L-glutamic acid

1.2 Other means of identification

Product number -
Other names 4-AMINOBENZOYLGLUTAMIC ACID

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4271-30-1 SDS

4271-30-1Synthetic route

Di-tert-butyl 3-fluoro,4-nitrobenzoyl-L-glutamate

Di-tert-butyl 3-fluoro,4-nitrobenzoyl-L-glutamate

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
With ammonium formate; palladium-carbon In methanol99%
p-Nitrobenzoyl-L-(+)-glutamic acid
6758-40-3

p-Nitrobenzoyl-L-(+)-glutamic acid

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
With palladium 10% on activated carbon; ammonium formate In methanol at 20℃; for 0.5h; Time; Concentration;96.58%
With palladium on carbon; hydrazine hydrate In ethanol at 80℃; for 2.5h;78%
With ethanol; palladium Hydrogenation;
dimethyl p-trifluoroacetamidobenzoyl-L-glutamate
233600-78-7

dimethyl p-trifluoroacetamidobenzoyl-L-glutamate

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
With sodium hydroxide; water In methanol at 23℃; for 4h;61%
diethyl N-(p-aminobenzoyl)-L-glutamate
13726-52-8

diethyl N-(p-aminobenzoyl)-L-glutamate

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

(S)-2-(4-(((2-amino-4-hydroxypteridin-6-yl)methyl)amino)benzamido)pentanedioic acid
59-30-3

(S)-2-(4-(((2-amino-4-hydroxypteridin-6-yl)methyl)amino)benzamido)pentanedioic acid

A

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

B

4-amino-benzoic acid
150-13-0

4-amino-benzoic acid

C

pterin-6-carboxylic acid
948-60-7

pterin-6-carboxylic acid

D

6-pterinaldehyde
712-30-1

6-pterinaldehyde

Conditions
ConditionsYield
With hydroxide In water Product distribution;
(S)-2-(4-(((2-amino-4-hydroxypteridin-6-yl)methyl)amino)benzamido)pentanedioic acid
59-30-3

(S)-2-(4-(((2-amino-4-hydroxypteridin-6-yl)methyl)amino)benzamido)pentanedioic acid

A

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

B

pterin-6-carboxylic acid
948-60-7

pterin-6-carboxylic acid

C

6-pterinaldehyde
712-30-1

6-pterinaldehyde

Conditions
ConditionsYield
With phosphate-buffered saline pH=7.4; UV-irradiation;
N-[4-[[(2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid

N-[4-[[(2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid

A

C20H23N7O6

C20H23N7O6

B

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
In phosphate buffer at 25 - 30℃; pH=7.4; Kinetics; UV-irradiation;
folic acid
59-30-3

folic acid

A

6-formylpterin
712-30-1

6-formylpterin

B

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
With oxygen; rose bengal In water-d2 pH=10.5; Kinetics; Irradiation;
L-glutamic acid
56-86-0

L-glutamic acid

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 79 percent / SOCl2 / 18 h / Ambient temperature
2: 70 percent / HOBt, DCC, DIEA / tetrahydrofuran / 48 h / -5 °C
3: 61 percent / NaOH, H2O / methanol / 4 h / 23 °C
View Scheme
Multi-step reaction with 2 steps
1: aq. NaOH solution
2: palladium; ethanol / Hydrogenation
View Scheme
4-(trifluoroacetamido)benzoic acid
404-26-2

4-(trifluoroacetamido)benzoic acid

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 70 percent / HOBt, DCC, DIEA / tetrahydrofuran / 48 h / -5 °C
2: 61 percent / NaOH, H2O / methanol / 4 h / 23 °C
View Scheme
2,2,2-trifluoro-N-(4-iodophenyl)acetamide
126063-08-9

2,2,2-trifluoro-N-(4-iodophenyl)acetamide

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) n-BuLi / 1.) ether, hexane, -78 deg C, 2 h, 2.) ether, hexane, -78 deg C to r.t.
2: 70 percent / HOBt, DCC, DIEA / tetrahydrofuran / 48 h / -5 °C
3: 61 percent / NaOH, H2O / methanol / 4 h / 23 °C
View Scheme
L-glutamic dimethyl ester hydrochloride
23150-65-4

L-glutamic dimethyl ester hydrochloride

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 70 percent / HOBt, DCC, DIEA / tetrahydrofuran / 48 h / -5 °C
2: 61 percent / NaOH, H2O / methanol / 4 h / 23 °C
View Scheme
p-aminoiodobenzene
540-37-4

p-aminoiodobenzene

p-chloro-benzenesulfonyl chloride

p-chloro-benzenesulfonyl chloride

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 78 percent / CH2Cl2 / 1 h / Ambient temperature
2: 1.) n-BuLi / 1.) ether, hexane, -78 deg C, 2 h, 2.) ether, hexane, -78 deg C to r.t.
3: 70 percent / HOBt, DCC, DIEA / tetrahydrofuran / 48 h / -5 °C
4: 61 percent / NaOH, H2O / methanol / 4 h / 23 °C
View Scheme
diethyl (4-nitrobenzoyl)-L-glutamate
7148-24-5

diethyl (4-nitrobenzoyl)-L-glutamate

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aqueous hydrochloric acid
2: palladium; ethanol / Hydrogenation
View Scheme
4-nitro-benzoyl chloride
122-04-3

4-nitro-benzoyl chloride

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: benzene
2: aqueous hydrochloric acid
3: palladium; ethanol / Hydrogenation
View Scheme
Multi-step reaction with 2 steps
1: benzene; calcium oxide / <40
2: aqueous ammonium sulfide
View Scheme
4-nitro-benzoic acid
62-23-7

4-nitro-benzoic acid

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: N,N-dimethyl-formamide; bis(trichloromethyl) carbonate / 1 h / 40 °C
2: sodium hydroxide / water / 1 h / 0 - 20 °C / pH 8
3: palladium 10% on activated carbon; ammonium formate / methanol / 0.5 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1.1: oxalyl dichloride / tetrahydrofuran; N,N-dimethyl-formamide / 55 °C
2.1: sodium hydroxide / water
2.2: 5 °C / pH 8
3.1: iron(III) chloride hexahydrate; hydrazine hydrate / methanol / 20 °C
View Scheme
folate
59-30-3

folate

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
In water UV-irradiation;
folate
59-30-3

folate

A

6-formylpterin
712-30-1

6-formylpterin

B

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

Conditions
ConditionsYield
With Pt(Py)2(N3)2(OH)2 In dimethylsulfoxide-d6; water-d2 at 37℃; for 2h; Irradiation;
N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

2-amino-4-hydroxy-6-bromomethylpteridine
89794-15-0

2-amino-4-hydroxy-6-bromomethylpteridine

(S)-2-(4-(((2-amino-4-hydroxypteridin-6-yl)methyl)amino)benzamido)pentanedioic acid
59-30-3

(S)-2-(4-(((2-amino-4-hydroxypteridin-6-yl)methyl)amino)benzamido)pentanedioic acid

Conditions
ConditionsYield
In N,N-dimethyl acetamide at 45℃; for 4h; Concentration; Temperature; Solvent; Industrial scale;89%
N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

2-amino-4-hydroxy-6-chloromethylpteridine

2-amino-4-hydroxy-6-chloromethylpteridine

(S)-2-(4-(((2-amino-4-hydroxypteridin-6-yl)methyl)amino)benzamido)pentanedioic acid
59-30-3

(S)-2-(4-(((2-amino-4-hydroxypteridin-6-yl)methyl)amino)benzamido)pentanedioic acid

Conditions
ConditionsYield
In methanol at 45℃; for 5h; Concentration; Temperature; Solvent; Industrial scale;85%
N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

2,5,6-triamino-1,4-dihydropyrimidin-4-one hydrochloride

2,5,6-triamino-1,4-dihydropyrimidin-4-one hydrochloride

folate
59-30-3

folate

Conditions
ConditionsYield
With 1,1,1-trichloroacetone; sodium sulfite In water at 40 - 50℃; for 1h; pH=3 - 4; pH-value; Temperature;85%
1,1,3-trichloroacetone
921-03-9

1,1,3-trichloroacetone

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

2,4,5-triamino-6-hydroxypyrimidine sulfate
35011-47-3

2,4,5-triamino-6-hydroxypyrimidine sulfate

folate
59-30-3

folate

Conditions
ConditionsYield
With sodium metabisulfite at 20 - 30℃; for 2h; Temperature; Ionic liquid;83.2%
With sodium metabisulfite; sodium acetate at 45℃; for 3h; Temperature;46.2%
N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

2-amino-6-(bromomethyl)-4(1H)-pteridinone hydrobromide
59212-10-1

2-amino-6-(bromomethyl)-4(1H)-pteridinone hydrobromide

folic acid
59-30-3

folic acid

Conditions
ConditionsYield
In N,N-dimethyl acetamide 1.) 22-25 deg C, 96 h; 2.) 50-60 deg C, 30 min; 3.) 22-25 deg C, 24 h;80%
1,1,3-trichloroacetone
921-03-9

1,1,3-trichloroacetone

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

2,4,5-triamino-6-hydroxypyrimidine sulfate
35011-47-3

2,4,5-triamino-6-hydroxypyrimidine sulfate

(S)-2-(4-(((2-amino-4-hydroxypteridin-6-yl)methyl)amino)benzamido)pentanedioic acid
59-30-3

(S)-2-(4-(((2-amino-4-hydroxypteridin-6-yl)methyl)amino)benzamido)pentanedioic acid

Conditions
ConditionsYield
With sodium hydroxide at 55℃; for 9h; pH=3;80%
Stage #1: 1,1,3-trichloroacetone; 2,4,5-triamino-6-hydroxypyrimidine sulfate With sodium metabisulfite In methanol; water for 0.5h; Large scale;
Stage #2: N-(4-aminobenzoyl)-L-glutamic acid With sodium hydroxide In methanol; water at 40 - 45℃; for 6h; pH=3 - 3.5; Solvent; Large scale;
69.7%
1,1,1-trichloroacetone
918-00-3

1,1,1-trichloroacetone

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

2,4,5-triamino-6-hydroxypyrimidine sulfate
35011-47-3

2,4,5-triamino-6-hydroxypyrimidine sulfate

folate
59-30-3

folate

Conditions
ConditionsYield
Stage #1: 1,1,1-trichloroacetone; N-(4-aminobenzoyl)-L-glutamic acid With sodium acetate; sodium sulfite In acetic acid at 43℃; for 0.5h;
Stage #2: 2,4,5-triamino-6-hydroxypyrimidine sulfate In acetic acid at 38℃; for 5h;
75.5%
6-bromomethyl-pteridine-2,4-diamine
59368-16-0

6-bromomethyl-pteridine-2,4-diamine

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

aminopterin
54-62-6

aminopterin

Conditions
ConditionsYield
In dimethylacetamide (DMAC) at 25℃; for 2h;68%
In ISOPROPYLAMIDE at 25℃; for 18h;68%
N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

water
7732-18-5

water

6-bromomethyl-2,4-diaminopteridine hydrobromide
52853-40-4

6-bromomethyl-2,4-diaminopteridine hydrobromide

aminopterin
54-62-6

aminopterin

Conditions
ConditionsYield
In ethanol68%
N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

<7-15N>guanide
128844-61-1

<7-15N>guanide

[3-(13)C]-D-glucose

[3-(13)C]-D-glucose

[5-15N][6-13C]-7,8-dihydrofolic acid

[5-15N][6-13C]-7,8-dihydrofolic acid

Conditions
ConditionsYield
Stage #1: [3-(13)C]-D-glucose With cysteine disulfide; pyruvate kinase from rabbit muscle; glutaredoxin 2; glucose-6-phosphate dehydrogenase from L. mesenteroides; glutathione reductase from baker’s yeast; hexokinase type F-300 from S. cerevisiae; myokinase from rabbit muscle; phosphoriboisomerase type I from spinach; potassium chloride; NADP; phospho(enol)pyruvic acid mono potassium salt; ATP; magnesium chloride In aq. buffer at 37℃; pH=7; Glovebox; Inert atmosphere; Enzymatic reaction;
Stage #2: With guanylate kinase; ribose-phosphate pyrophosphokinase; xanthine guanine phosphoribosyl transferase In aq. buffer for 0.25h; Glovebox; Inert atmosphere; Enzymatic reaction;
Stage #3: N-(4-aminobenzoyl)-L-glutamic acid; <7-15N>guanide Further stages;
30%
D-Glucose
2280-44-6

D-Glucose

2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

(S)-2-{4-[(2-Amino-4-oxo-3,4,7,8-tetrahydro-pteridin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid
4033-27-6

(S)-2-{4-[(2-Amino-4-oxo-3,4,7,8-tetrahydro-pteridin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid

Conditions
ConditionsYield
Stage #1: D-Glucose With cysteine disulfide; pyruvate kinase from rabbit muscle; glutaredoxin 2; glucose-6-phosphate dehydrogenase from L. mesenteroides; glutathione reductase from baker’s yeast; hexokinase type F-300 from S. cerevisiae; myokinase from rabbit muscle; phosphoriboisomerase type I from spinach; NADP; phospho(enol)pyruvic acid mono potassium salt; ATP In aq. buffer at 37℃; pH=7; Glovebox; Inert atmosphere; Enzymatic reaction;
Stage #2: With guanylate kinase; ribose-phosphate pyrophosphokinase; xanthine guanine phosphoribosyl transferase In aq. buffer for 0.25h; Glovebox; Inert atmosphere; Enzymatic reaction;
Stage #3: 2-amino-1,9-dihydro-6H-purin-6-one; N-(4-aminobenzoyl)-L-glutamic acid Further stages;
30%
N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

2-amino-O4-benzyl-6-formylpteridine
737817-22-0

2-amino-O4-benzyl-6-formylpteridine

O4-benzylfolic acid

O4-benzylfolic acid

Conditions
ConditionsYield
With sodium cyanoborohydride In N,N-dimethyl-formamide for 0.0833333h;17.7%
Stage #1: N-(4-aminobenzoyl)-L-glutamic acid; 2-amino-O4-benzyl-6-formylpteridine In DMF (N,N-dimethyl-formamide)
Stage #2: With sodium cyanoborohydride; acetic acid In DMF (N,N-dimethyl-formamide) for 0.0833333h;
17.7%
2,5,6-triamino-3,4-dihydro-4-pyrimidinone
1004-75-7

2,5,6-triamino-3,4-dihydro-4-pyrimidinone

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

<1,1,3-13C2> trichloroacetone

<1,1,3-13C2> trichloroacetone

<7,9-13C2> folic acid

<7,9-13C2> folic acid

Conditions
ConditionsYield
With sodium hydrogencarbonate; sodium hydrogensulfite; <1,3-13C2> dichloroacetone In ethanol for 72h; pH 4.0;10%
methanol
67-56-1

methanol

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

dimethyl N-(4-amino-benzoyl)-L-glutamate
52407-60-0

dimethyl N-(4-amino-benzoyl)-L-glutamate

Conditions
ConditionsYield
With acetyl chloride
4-chloroquinazoline
5190-68-1

4-chloroquinazoline

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

N-(4-quinazolin-4-ylamino-benzoyl)-L-glutamic acid

N-(4-quinazolin-4-ylamino-benzoyl)-L-glutamic acid

Conditions
ConditionsYield
With ethanol
formic acid
64-18-6

formic acid

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

N-(4-formylamino-benzoyl)-L-glutamic acid
93528-16-6

N-(4-formylamino-benzoyl)-L-glutamic acid

4,5,6-triamino-1H-pyrimidine-2-thione
1073-99-0

4,5,6-triamino-1H-pyrimidine-2-thione

2,3-dibromopropanal
5221-17-0

2,3-dibromopropanal

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

N-{4-[(4-amino-2-thioxo-1,2-dihydro-pteridin-6-ylmethyl)-amino]-benzoyl}-L-glutamic acid
103207-69-8

N-{4-[(4-amino-2-thioxo-1,2-dihydro-pteridin-6-ylmethyl)-amino]-benzoyl}-L-glutamic acid

5,6-diaminouracil
3240-72-0

5,6-diaminouracil

2,3-dibromopropanal
5221-17-0

2,3-dibromopropanal

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

N-{4-[(2,4-dioxo-1,2,3,4-tetrahydro-pteridin-6-ylmethyl)-amino]-benzoyl}-L-glutamic acid
25663-25-6

N-{4-[(2,4-dioxo-1,2,3,4-tetrahydro-pteridin-6-ylmethyl)-amino]-benzoyl}-L-glutamic acid

Conditions
ConditionsYield
With sodium acetate; acetic acid
5,6-diaminouracil
3240-72-0

5,6-diaminouracil

1,1,3-tribromoacetone
3475-39-6

1,1,3-tribromoacetone

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

N-{4-[(2,4-dioxo-1,2,3,4-tetrahydro-pteridin-6-ylmethyl)-amino]-benzoyl}-L-glutamic acid
25663-25-6

N-{4-[(2,4-dioxo-1,2,3,4-tetrahydro-pteridin-6-ylmethyl)-amino]-benzoyl}-L-glutamic acid

Conditions
ConditionsYield
With aqueous solution of pH 1-5
2,5,6-triamino-3,4-dihydro-4-pyrimidinone
1004-75-7

2,5,6-triamino-3,4-dihydro-4-pyrimidinone

1,1,3-trichloroacetone
921-03-9

1,1,3-trichloroacetone

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

folic acid
59-30-3

folic acid

2,5,6-triamino-3,4-dihydro-4-pyrimidinone
1004-75-7

2,5,6-triamino-3,4-dihydro-4-pyrimidinone

1,1,3-tribromoacetone
3475-39-6

1,1,3-tribromoacetone

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

folic acid
59-30-3

folic acid

2,5,6-triamino-3,4-dihydro-4-pyrimidinone
1004-75-7

2,5,6-triamino-3,4-dihydro-4-pyrimidinone

2,2,3-tribromopropanal
26944-17-2

2,2,3-tribromopropanal

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

folic acid
59-30-3

folic acid

2,5,6-triamino-3,4-dihydro-4-pyrimidinone
1004-75-7

2,5,6-triamino-3,4-dihydro-4-pyrimidinone

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

N-((Ξ)-9-methyl-pteroyl)-L-glutamic acid
2179-16-0

N-((Ξ)-9-methyl-pteroyl)-L-glutamic acid

Conditions
ConditionsYield
With 2,2,3-trichlorobutyraldehyde
3-phthalimidopropionyl chloride
17137-11-0

3-phthalimidopropionyl chloride

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

N-{4-[(N,N-phthaloyl-β-alanyl)-amino]-benzoyl}-L-glutamic acid

N-{4-[(N,N-phthaloyl-β-alanyl)-amino]-benzoyl}-L-glutamic acid

Conditions
ConditionsYield
With 1,4-dioxane; water; magnesium oxide

4271-30-1Relevant articles and documents

Reactivity of conjugated and unconjugated pterins with singlet oxygen (O2(1Δg)): Physical quenching and chemical reaction

Cabrerizo, Franco M.,Laura Dantola,Petroselli, Gabriela,Capparelli, Alberto L.,Thomas, Andres H.,Braun, Andre M.,Lorente, Carolina,Oliveros, Esther

, p. 526 - 534 (2007)

Pterins (PTs) belong to a class of heterocyclic compounds present in a wide range of living systems. They participate in relevant biological functions and are involved in different photobiological processes. We have investigated the reactivity of conjugated PTs (folic acid [FA], 10-methylfolic acid [MFA], pteroic acid [PA]) and unconjugated PTs (PT, 6-hydroxymethylpterin [HPT], 6-methylpterin [MPT], 6,7-dimethylpterin [DPT], rhamnopterin [RPT]) with singlet oxygen (1O2) in aqueous solutions, and compared the efficiencies of chemical reaction and physical quenching. The chemical reactions between 1O2, produced by photosensitization, and PT derivatives were followed by UV-visible spectrophotometry and high-performance liquid chromatography, and corresponding rate constants (kr) were evaluated. Whenever possible, products were identified and quantified. Rate constants of 1O2 total quenching by the PT derivatives investigated were obtained from steady-state 1O2 luminescence measurements. Results show that the behavior of conjugated PTs differs considerably from that of unconjugated derivatives, and the mechanisms of 1O2 physical quenching by these compounds and of their chemical reaction with 1O2 are discussed in relation to their structural features.

Effect of pterin impurities on the fluorescence and photochemistry of commercial folic acid

Dántola, M. Laura,Urrutia, M. Noel,Thomas, Andrés H.

, p. 157 - 163 (2018)

Folic acid, or pteroyl?L?glutamic acid (PteGlu) is a conjugated pterin derivative that is used in dietary supplementation as a source of folates, a group of compounds essential for a variety of physiological functions in humans. Photochemistry of PteGlu is important because folates are not synthesized by mammals, undergo photodegradation and their deficiency is related to many diseases. We have demonstrated that usual commercial PteGlu is unpurified with the unconjugated oxidized pterins 6?formylpterin (Fop) and 6?carboxypterin (Cap). These compounds are in such low amounts that a normal chromatographic control would not detect any pterinic contamination. However, the fluorescence of PteGlu solutions is due to the emission of Fop and Cap and the contribution of the PteGlu emission, much lower, is negligible. This is because the fluorescence quantum yield (ΦF) of PteGlu is extremely weak compared to the ΦF of Fop and Cap. Likewise, the PteGlu photodegradation upon UV-A radiation is an oxidation photosensitized by oxidized unconjugated pterins present in the solution, and not a process initiated by the direct absorption of photons by PteGlu. In brief, the fluorescence and photochemical properties of PteGlu solutions, prepared using commercially available solids, are due to their unconjugated pterins impurities and not to PteGlu itself. This fact calls into question many reported studies on fluorescence and photooxidation of this compound.

Unexpected photoactivation pathways in a folate-receptor-targetedtrans-diazido Pt(iv) anticancer pro-drug

Gandioso, Albert,Marchán, Vicente,Rovira, Anna,Sadler, Peter J.,Shi, Huayun

, p. 11828 - 11834 (2020)

A conjugate between a photoactivetrans-diazido Pt(iv) pro-drug,trans,trans,trans-[Pt(N3)2(OH)2(py)2], and folic acid has been synthesized and fully characterized by high resolution ESI-MS, NMR and UV-vis spectroscopy. Photoactivation of the Pt-folate conjugate with visible light confirmed the generation of cytotoxic Pt(ii) species capable of binding to guanine nucleobases. Importantly, photoreduction of the Pt(iv) complex triggered the photodecomposition of the folate vector into ap-aminobenzoate-containing fragment and several pterin derivatives, including 6-formylpterin. Besides exhibiting high dark stability in physiological-like conditions, the Pt-folate conjugate wasca. 2× more photocytotoxic towards MCF-7 breast cancer cell line than its parent Pt(iv) complex with a high photoselectivity index (PI > 6.9). The higher photocytotoxicity of the conjugate may be a consequence of its higher cellular accumulation and of the generation of a set of different cytotoxic species, including Pt(ii) photoproducts and several pterin derivatives, which are known to generate ROS.

Influence of human serum albumin on photodegradation of folic acid in solution

Vorobey, Pavel,Steindal, Arnfinn Engeset,Off, Morten Kristian,Vorobey, Alexander,Moan, Johan

, p. 817 - 822 (2006)

It has been proposed that photodegradation of folates may be the reason for the pigmentation of races living under high fluence rates of ultraviolet radiation. The photodegradation of folic acid (FA) induced by ultraviolet-A (UV-A) radiation, in solution and in the presence of human serum albumin (HSA), was studied with absorption and fluorescence spectroscopy. FA photodegradation, with formation of p-aminobenzoyl-L-glutamic acid, 6-formylpterin and pterin-6-carboxylic acid, was found to follow an exponential trend. A scheme of FA photodegradation, which involves photosensitization of FA degradation by its photoproducts, was proposed. The rate of FA photodegradation decreased drastically in the presence of HSA, whereas the spectral characteristics of the photoproducts remained constant. The reduction of the FA photodegradation rate by HSA was accompanied by degradation of tryptophan in HSA. Tryptophan, when added to solutions of FA, had a similar effect as HSA. In solutions of FA and HSA the FA photoproducts cause photodamage mainly to HSA rather than to FA itself. The oxygen dependence of FA photodegradation and the inhibition of this process by sodium azide indicate that singlet oxygen may participate in the photosensitizing activity of FA photoproducts.

Preparation method of N-p-aminobenzoyl-L-glutamic acid

-

Paragraph 0015; 0019; 0020; 0021; 0022; 0024, (2018/07/15)

The invention discloses a preparation method of N-p-aminobenzoyl-L-glutamic acid. The preparation method comprises the following steps of: (1) adopting p-nitrobenzoic acid as a starting material, adopting oxalyl chloride as an acylating chlorination reagent, adopting tetrahydrofuran and DMF (Dimethyl Formamide) as a mixed solvent, and carrying out acylating chlorination reaction to prepare paranitrobenzoyl chloride; (2) carrying out condensation reaction of the paranitrobenzoyl chloride prepared in the step (1) and sodium glutamate to prepare N-p-nitrobenzoyl-L-glutamic acid; (3) adopting hydrazine hydrate as a reducing agent, adopting ferric trichloride hexahydrate as a catalyst, and carrying out reducing reaction of the N-p-nitrobenzoyl-L-glutamic acid prepared in the step (2) to preparethe N-p-aminobenzoyl-L-glutamic acid. The preparation method disclosed by the invention has the beneficial effects that the acylating chlorination reaction selects the oxalyl chloride as the acylating chlorination reagent in the mixed solvent of the tetrahydrofuran and the DMF, the reducing reaction selects the hydrazine hydrate as the reducing agent and selects the ferric trichloride hexahydrateas the catalyst, and finally the N-p-aminobenzoyl-L-glutamic acid with the purity being more than or equal to 99.9% can be obtained.

Preparation method of N (4-aminobenzoyl)-L-glutamic acid

-

Paragraph 0029; 0030, (2016/10/31)

The invention provides a preparation method of N (4-aminobenzoyl)-L-glutamic acid. According to the method, p-nitrobenzoic acid is taken as a raw material, BTC/C2H4Cl1 is taken as an acylating chlorination agent, DMF (dimethyl formamide) is added to serve as an initiator, and p-nitrobenzoyl chloride is prepared through reaction at a reflux temperature; p-nitrobenzoyl chloride and sodium glutamate have condensation, and N-(4-nitrobenzoyl)-L-glutamic acid is prepared; N-(4-nitrobenzoyl)-L-glutamic acid is reduced by Pd/C/HCO2NH4, and N (4-aminobenzoyl)-L-glutamic acid is prepared. The preparation method has mild reaction conditions and is simple in process, easy to operate and suitable for industrial production; few three wastes are generated, and a product has high purity and high yield.

Resolution of (±)-β-methylphenylethylamine by a novel chiral stationary phase for Pirkle-type column chromatography

Yilmaz, Hayrullah,Topal, Giray,Cakmak, Resit,Hosgoren, Halil

experimental part, p. 252 - 257 (2010/12/18)

In this study, a new Pirkle-type chiral column stationary phase for resolution of β-methylphenylethyl amine was described by using activated Sepharose 4B as a matrix, L-tyrosine as a spacer arm, and an aromatic amine derivative of L-glutamic acid as a ligand. The binding capacities of the stationary phase were determined at different pH values (pH = 6, 7, and 8) using buffer solutions as mobile phase, and enantiomeric excess (ee) was determined by HPLC equipped with chiral column. The ee was found to be 47%.

Photodegradation of 5-methyltetrahydrofolate: Biophysical Aspects

Steindal, Arnfinn Hykkerud,Juzeniene, Asta,Johnsson, Anders,Moan, Johan

, p. 1651 - 1655 (2008/02/13)

5-methyltetrahydrofolate (5MTHF) absorbs UV radiation and has an absorption coefficient of 24250 ± 1170 M-1 cm-1 at 290 nm. It has a weak fluorescence emission in the wavelength region around 360 nm. Our data demonstrated induction of 5-methyldihydrofolate by exposure to UVB and, after continues irradiation, p-aminobenzoyl-L-glutamic acid was found. The photodegradation of 5MTHF follows a first order kinetic with a degradation rate constant of 9.2 × 10-3 min-1 under our conditions (fluence rate of 2.15 mW cm-2, exposure wavelengths from 280 to 350 nm). Our results indicate that a direct degradation of 5MTHF by UV exposure in humans in vivo is rather unlikely. 5MTHF mainly absorbs, and is degraded by, UVB and UVC, radiation that does not penetrate the earth's atmosphere and the human skin well.

Possible role of hydroxyl radicals in the oxidative degradation of folic acid

Patro, Birija S.,Adhikari, Soumyakanti,Mukherjee, Tulsi,Chattopadhyay, Subrata

, p. 67 - 71 (2007/10/03)

An unprecedented .OH radical-induced N-dealkylation of amines including folic acid is reported, the reaction proceeding via a direct hydrogen atom abstraction mechanism as revealed by pulse radiolysis experiments. Hydroxyl radicals have been found to cause oxidative N-dealkylation of amines including folic acid via a hydrogen atom transfer mechanism.

The synthesis of folic acid, multiply labelled with stable isotopes, for bio-availability studies in human nutrition

Maunder, Peter,Finglas, Paul M.,Mallet, Anthony I.,Mellon, Fred A.,Aaqib Razzaque,Ridge, Brian,Vahteristo, Liisa,Witthoeft, Cornelia

, p. 1311 - 1323 (2007/10/03)

Two different methods for the synthesis of folic acid, which are suitable for the incorporation of compounds multiply labelled with stable isotopes, are described. The first method is based on the use of a novel reductive amination to link 2-acetyIamino-4-hydroxy-6-formylpteridine withp-aminobenzoyl-L-glutamic acid. The second method is based on the penultimate formation of an amide bond between Ar-2-acetyl-Ar-10-trifluoroacetyIpteroic acid and dimethyl L-glutamate. Both methods have been used to transform [13C6]aniline into folic acid, labelled with [13C6] in the p-aminobenzoate moiety, and [3,3,4,4-2H4]-L-glutamic acid into folic acid, labelled with [2H4] in the glutamate moiety. Doubly labelled [13C6,2H 4]-p-aminobenzoyl-L-glutamate has also been prepared by the former method.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4271-30-1